日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Re-analysis of hepatitis B virus integration sites reveals potential new loci associated with oncogenesis in hepatocellular carcinoma

对乙型肝炎病毒整合位点的重新分析揭示了与肝细胞癌发生相关的潜在新位点

Kojima, Ryuta; Nakamoto, Shingo; Kogure, Tadayoshi; Ma, Yaojia; Ogawa, Keita; Iwanaga, Terunao; Qiang, Na; Ao, Junjie; Nakagawa, Ryo; Muroyama, Ryosuke; Nakamura, Masato; Chiba, Tetsuhiro; Kato, Jun; Kato, Naoya

The RNA-Binding Protein ELAVL1 Regulates Hepatitis B Virus Replication and Growth of Hepatocellular Carcinoma Cells

RNA结合蛋白ELAVL1调控乙型肝炎病毒复制和肝细胞癌细胞生长

Kanzaki, Hiroaki; Chiba, Tetsuhiro; Kaneko, Tatsuya; Ao, Junjie; Kan, Motoyasu; Muroyama, Ryosuke; Nakamoto, Shingo; Kanda, Tatsuo; Maruyama, Hitoshi; Kato, Jun; Zen, Yoh; Kotani, Ai; Sekiba, Kazuma; Otsuka, Motoyuki; Ohtsuka, Masayuki; Kato, Naoya

Effect of Atezolizumab plus Bevacizumab in Patients with Hepatocellular Carcinoma Harboring CTNNB1 Mutation in Early Clinical Experience

阿特珠单抗联合贝伐珠单抗治疗携带 CTNNB1 突变的肝细胞癌患者的早期临床经验

Ogawa, Keita; Kanzaki, Hiroaki; Chiba, Tetsuhiro; Ao, Junjie; Qiang, Na; Ma, Yaojia; Zhang, Jiaqi; Yumita, Sae; Ishino, Takamasa; Unozawa, Hidemi; Kan, Motoyasu; Iwanaga, Terunao; Nakagawa, Miyuki; Fujiwara, Kisako; Fujita, Naoto; Sakuma, Takafumi; Koroki, Keisuke; Kusakabe, Yuko; Kobayashi, Kazufumi; Kanogawa, Naoya; Kiyono, Soichiro; Nakamura, Masato; Kondo, Takayuki; Saito, Tomoko; Nakagawa, Ryo; Ogasawara, Sadahisa; Suzuki, Eiichiro; Nakamoto, Shingo; Muroyama, Ryosuke; Kanda, Tatsuo; Maruyama, Hitoshi; Mimura, Naoya; Kato, Jun; Motohashi, Shinichiro; Kato, Naoya

Serum Angiopoietin 2 acts as a diagnostic and prognostic biomarker in hepatocellular carcinoma.

血清血管生成素 2 可作为肝细胞癌的诊断和预后生物标志物

Ao Junjie, Chiba Tetsuhiro, Kanzaki Hiroaki, Kanayama Kengo, Shibata Shuhei, Kurosugi Akane, Iwanaga Terunao, Kan Motoyasu, Sakuma Takafumi, Qiang Na, Ma Yaojia, Kojima Ryuta, Kusakabe Yuko, Nakamura Masato, Kobayashi Kazufumi, Kiyono Soichiro, Kanogawa Naoya, Saito Tomoko, Nakagawa Ryo, Kondo Takayuki, Ogasawara Sadahisa, Suzuki Eiichiro, Nakamoto Shingo, Muroyama Ryosuke, Tawada Akinobu, Kato Jun, Kanda Tatsuo, Maruyama Hitoshi, Kato Naoya

Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinoma

血清成纤维细胞生长因子19可作为肝细胞癌的一种潜在新型生物标志物。

Maeda, Takahiro; Kanzaki, Hiroaki; Chiba, Tetsuhiro; Ao, Junjie; Kanayama, Kengo; Maruta, Susumu; Kusakabe, Yuko; Saito, Tomoko; Kobayashi, Kazufumi; Kiyono, Soichiro; Nakamura, Masato; Ogasawara, Sadahisa; Suzuki, Eiichiro; Ooka, Yoshihiko; Nakamoto, Shingo; Nakagawa, Ryo; Muroyama, Ryosuke; Kanda, Tatsuo; Maruyama, Hitoshi; Kato, Naoya